NCT04221360View on ClinicalTrials.gov

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375

PHASE1UnknownINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 29, 2020

Primary Completion Date

March 6, 2020

Study Completion Date

June 8, 2020

Conditions
Type2 Diabetes Mellitus
Interventions
DRUG

CKD-375

Test drug, QD, PO

DRUG

D390

Reference drug, QD, PO

Trial Locations (1)

Unknown

Yonsei University Severance Hospital, Soeul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY